ZHENG; Shilong

Patent Applications and Registrations

Patent applications and USPTO patent grants for ZHENG; Shilong.The latest application filed is for "inhibitors of androgen receptor signaling".

Company Profile

2.7.10

ZHENG; Shilong - New Orleans LA
Zheng; Shilong - Atlanta GA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Inhibitors Of Androgen Receptor Signaling App 20210284663 - WANG; Guangdi ; et al.	2021-09-16
Enhanced osteogenic activity of daidzein analogs on human mesenchymal stem cells Grant 11,098,053 - Strong , et al. August 24, 2	2021-08-24
Boronic derivatives of hydroxamates as anticancer agents Grant 11,046,715 - Wang , et al. June 29, 2	2021-06-29
Boronic Derivatives Of Hydroxamates As Anticancer Agents App 20200181175 - WANG; Guangdi ; et al.	2020-06-11
Selective Estrogen Receptor Down-regulators (serds) App 20190233442 - WANG; Guangdi ; et al.	2019-08-01
Boron-based prodrug strategy for increased bioavailability and lower-dosage requirements for drug molecules containing at least one phenol (or aromatic hydroxyl) group Grant 10,112,962 - Wang , et al. October 30, 2	2018-10-30
Boron-based Prodrug Strategy For Increased Bioavailability And Lower-dosage Requirements For Drug Molecules Containing At Least One Phenol (or Aromatic Hydroxyl) Group App 20170137443 - WANG; Guangdi ; et al.	2017-05-18
Anti-migration and anti-invasion thiazole analogs for treatment of cellular proliferative disease Grant 9,650,369 - Wang , et al. May 16, 2	2017-05-16
Anti-vasculature And Anti-tubulin Combretastatin Analogs For Treatment Of Cancer App 20170044103 - WANG; Guangdi ; et al.	2017-02-16
Boron-based 4-hydroxytamoxifen and endoxifen prodrugs as treatment for breast cancer Grant 9,353,132 - Wang , et al. May 31, 2	2016-05-31
Enhanced Osteogenic Activity of Daidzein Analogs on Human Mesenchymal Stem Cells App 20160068542 - SHI; Zhenzhen ; et al.	2016-03-10
Anti-migration And Anti-invasion Thiazole Analogs For Treatment Of Cellular Proliferative Disease App 20150274714 - Wang; Guangdi ; et al.	2015-10-01
Boron-based 4-hydroxytamoxifen And Endoxifen Prodrugs As Treatment For Breast Cancer App 20150080339 - Wang; Guangdi ; et al.	2015-03-19
Compositions for regulating or modulating quorum sensing in bacteria, methods of using the compounds, and methods of regulating or modulating quorum sensing in bacteria Grant 8,653,258 - Wang , et al. February 18, 2	2014-02-18
Compositions For Regulating Or Modulating Quorum Sensing In Bacteria, Methods Of Using The Compounds, And Methods Of Regulating Or Modulating Quorum Sensing In Bacteria App 20100137249 - Wang; Binghe ; et al.	2010-06-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.